Results showed that both parthenolide and TAK-242 dose-dependently lowered protein levels of TLR4, STAT3 and phosphorylated STAT3 (Fig. 6a) in and inhibited the proliferation (Fig. 6b) of A375 and B16 melanoma cells. Here, TLR4 is linked to melanoma.